MedTrace Logo

A 2-Month Safety Follow-Up Trial

NCT00741429 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 649

Last updated 2014-12-03

No results posted yet for this study

Summary

The main purpose of the trial is to evaluate pulmonary function in subjects who had completed any one of the 4 MKC parent trials (MKC-TI-009, MKC-TI-102, MKC-TI-103, or MKC-TI-030) for an additional 2-month safety follow-up.

Conditions

Interventions

DRUG

Technosphere Insulin Inhalation Powder

Subjects previously treated with Technosphere Insulin Inhalation Powder

DRUG

Comparator

Subjects previously treated with other anti-diabetic medications

Sponsors & Collaborators

  • Mannkind Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2008-09-30
Completion
2008-09-30

Countries

  • United States
  • Brazil
  • Canada
  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00741429 on ClinicalTrials.gov